Mammals are vulnerable to a number of diseases that cause blindness through permanent retinal cell loss. Previous work has shown that expression of the proneural transcription factor Ascl1 in mouse […] Read More
As an ISCRM postdoctoral fellow, Evelyn Abraham will validate reprogramming of human Müller glia as a treatment for retinal degenerative diseases. She will use patient-derived retinal organoids to model late-stage […] Read More
ISCRM fellowship funding will allow Marina Pavlou, PhD to test the potential of growth factors Ascl1 and Atoh1 to reinstate developmental plasticity in adult non-human primate Müller glia. The goal […] Read More